Welcome to our dedicated page for C H Robinson Worldwide SEC filings (Ticker: CHRW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
C.H. Robinson Worldwide, Inc. filings document the regulatory record of a Delaware-based public logistics company listed on Nasdaq under CHRW. Its Form 8-K reports furnish quarterly financial results, earnings call materials, operating-income targets, share repurchase authorizations, and Regulation FD updates tied to its freight brokerage, forwarding, and transportation-management operations.
The company’s proxy materials cover board elections, director compensation, executive pay, shareholder voting matters, and governance practices. Other filings record board appointments and committee assignments, director departures, material agreements, and financing arrangements, including amendments to a receivables securitization facility involving C.H. Robinson Receivables, LLC. These disclosures also reflect capital-allocation actions, risk factors, ownership matters, and formal governance changes.
C.H. Robinson Worldwide (CHRW) reported insider activity by its Pres, NAST. On 11/03/2025, the officer exercised options for 45,266 shares of common stock via multiple transactions at exercise prices of $76.72, $87.15, $88.87, and $72.74. The same day, the officer sold 26,050 shares at a weighted average price of $151.476 and 19,216 shares at $151.995. On 11/04/2025, the officer reported a gift of 658 shares.
Following the reported transactions, beneficial ownership was 33,388 shares. This amount includes 30,646 shares issuable upon settlement of restricted stock units and deferred shares, and 2,245 shares held directly.
C.H. Robinson Worldwide (CHRW) reported stronger profitability in Q3 2025. Net income rose to $162.987 million with diluted EPS of $1.34, up from $0.80 a year ago, as operating income improved to $220.836 million. Revenue declined to $4.137 billion from $4.645 billion, reflecting lower Global Forwarding activity, while NAST remained relatively steady. The effective tax rate fell to 20.6% from 32.4%, and interest and other expense improved year over year.
For the first nine months, revenue was $12.320 billion (down from $13.540 billion), yet net income increased to $450.760 million and diluted EPS reached $3.71. Cash provided by operating activities strengthened to $609.105 million. The company completed the sale of its Europe Surface Transportation business effective February 1, 2025. CHRW initiated a 2025 restructuring program focused on automation and facility consolidation, recording $9.9 million in Q3 charges and $13.8 million year‑to‑date, with total expected charges of $50–$75 million over three years. As of October 29, 2025, shares outstanding were 118,137,178.
C.H. Robinson Worldwide (CHRW) furnished materials announcing quarterly results for the period ended September 30, 2025 and provided related earnings slides. The company also announced a raised 2026 operating income target and an additional $2 billion share repurchase authorization.
The updates were furnished as Exhibits 99.1, 99.2, and 99.3. The repurchase authorization signals board approval to buy back shares up to the stated amount, while the higher 2026 operating income target reflects the company’s updated outlook for profitability. Specific financial figures for the quarter are contained in the accompanying press release and slide deck.
C.H. Robinson Worldwide (CHRW) furnished materials announcing quarterly results for the period ended September 30, 2025 and provided related earnings slides. The company also announced a raised 2026 operating income target and an additional $2 billion share repurchase authorization.
The updates were furnished as Exhibits 99.1, 99.2, and 99.3. The repurchase authorization signals board approval to buy back shares up to the stated amount, while the higher 2026 operating income target reflects the company’s updated outlook for profitability. Specific financial figures for the quarter are contained in the accompanying press release and slide deck.
Timothy C. Gokey, a director of C. H. Robinson Worldwide, Inc. (CHRW), reported a non-derivative acquisition on 09/30/2025 of 256 phantom shares/restricted stock units that will be paid one-for-one in common stock. The RSUs were granted because he elected to defer his most recent quarterly cash retainer and are described as immediately vested. Following the reported award, Mr. Gokey beneficially owns 25,413 shares of common stock directly. The RSUs become payable in shares according to the payout schedule he previously selected after he ends service as a director. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
C.H. Robinson Worldwide reported that board member Henry W. “Jay” Winship resigned from its Board of Directors effective August 25, 2025. The company stated that his resignation was not due to any disagreement related to its operations, policies, or practices, indicating a routine governance change rather than a dispute-driven departure.
Form 144 notice for C.H. Robinson Worldwide, Inc. (CHRW) reports a proposed open‑market sale of 266,732 common shares on 08/27/2025 through Charles Schwab. The filing shows an aggregate market value of $34,080,348 and 118,091,162 shares outstanding, indicating the sale is a small fraction of total shares. The shares being offered were acquired in two open‑market purchases on 02/23/2022 (116,100 shares) and 02/24/2022 (150,632 shares), with broker checks used for payment. The filer states there were no securities sold in the past three months for the account and attests not to possessing undisclosed material adverse information.
Rajan Arun, Chief Strategy & Innovation Officer of C.H. Robinson Worldwide, Inc. (CHRW), reported a sale of 2,500 shares of common stock on 08/15/2025 at a price of $121.74 per share. The filing states the sale was made pursuant to a 10b5-1(c) plan adopted on 05/08/2025. After the reported transaction, the reporting person beneficially owns 130,591 shares, which the filing explains include 91,210 shares issuable on settlement of restricted stock units and deferred shares credited to a NQDC plan account and 38,994 shares held directly; an additional 387 shares were acquired under the employee stock purchase plan. The form is signed by an attorney-in-fact and contains only the insider transaction and ownership breakdown disclosed above.
C.H. Robinson Worldwide, Inc. (CHRW) filed a Form 144 notifying the proposed sale of 2,500 common shares through Fidelity Brokerage Services with an aggregate market value of $304,350.00. The filing lists approximately 118,091,162 shares outstanding and an approximate sale date of 08/15/2025 on NASDAQ. The shares were acquired on 09/01/2022 upon restricted stock vesting from the issuer and were received as compensation. The filer reports no sales of the issuer's securities in the past three months. Several filer identification fields in the provided content (including CIK and contact details) appear blank in the copy provided.
Insider sale reported by Angela K. Freeman, CHRO and ESG Officer of C.H. Robinson Worldwide (CHRW). The Form 4 discloses that on 08/11/2025 Freeman disposed of 5,713 shares of CHRW common stock in multiple transactions at a weighted average price of $116.243 per share, with sale prices ranging from $116.11 to $116.48.
After the reported sale the reporting person beneficially owns 65,728 shares, comprised of 65,459 shares issuable upon settlement of restricted stock units and deferred plan credits and 269 shares held directly. No derivative securities were reported and the Form 4 was filed by one reporting person.
Edward G. Feitzinger, a director of C.H. Robinson (CHRW), was granted 1,270 restricted stock units (phantom shares) on 08/07/2025 as a pro-rated portion of the annual equity-based award for non-employee directors. Each unit will be paid in one share of common stock. The restricted stock units are immediately vested and, following the reporting person's termination of service as a director, become payable in shares according to the payment schedule previously chosen by the reporting person. The grant is reported as a direct acquisition of derivative securities at a $0 price.